HGH vs NCC

ASX Financial Services sector comparison — updated 25 Mar 2026 — Financial Services sector

HGH

HEARTLAND FPO NZX [HGH]

53MEDIUM

NCC

NAOS EMERG FPO [NCC]

55MEDIUM

Score Breakdown

HGH NCC
Technical
55
79
Catalyst
51
53
Sentiment
50
50
Fundamental
94
100
Momentum
80
83
Risk Gate
42
46

Key Metrics

HGH Metric NCC
$1.0BMarket Cap$32.1M
9KAvg Volume (20d)94K
N/AShort InterestN/A
$1.11052-Week High$0.470
$0.66052-Week Low$0.230
+0.0%Daily Change+3.8%
$0.985Entry Price$0.440
+6.7%ROE+9.8%
+27.2%Profit Margin+53.1%

Active Signals

HGH Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Volume surging at 5.4x normal while price falls — heavy selling pressure
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 3.4% over the last 5 days

NCC Signals

●MACD momentum is picking up steam
●Trading above both moving averages — the trend is your friend here
●Above-average volume (1.5x) on a green day — buyers stepping up
●Knocking on the door of resistance — if it punches through, things could get interesting
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (4.1x)
●Strong revenue growth (+77%)

Ask Scout AI to compare HGH and NCC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
HGH Full Analysis → NCC Full Analysis → Financial Services Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).